Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Medscape Oncology to Make a Significant Impact at ASCO 2024

May 31, 2024 |  

- PMLiVE

ASCO is one of the biggest conferences of the year for Medscape Oncology, and the team is ready to make an impact in Chicago. They’ll be manning booth #26030, where they’ll be chatting with conference attendees about all things Medscape, oncology education, and patient centricity. The Medscape booth will also house a full recording studio where faculty members will gather to film future education programs.

The Medscape team will also host five educational symposia led by oncology experts that will help share the latest data and information, and provide learners with the opportunity to network and ask questions. The symposia will cover topics such as glioma care, relapsed diffuse large B-cell lymphoma, metastatic colorectal cancer, NSCLC management, and relapsed follicular lymphoma. Medscape members will be able to apply for credit for the events.

As part of their commitment to publication, Medscape will also present three scientific posters online at ASCO.org on the impact of CME and micro CE/CME. 

For more information on oncology education at Medscape, please contact Chris Carey (ccarey@medscape.net) 

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

ESMO’s New Focus on Cancer Prevention

During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...

ESMO Patient Centricity – Highlights from Steve Clark

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...

ESMO Patient Centricity Highlights from Dr. Whyte

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...

Closing The Gaps in Patient-Centricity in Cancer Care

Highlights from the Medscape Education full panel discussion during this year's #ESMO22.